ENOXAPARIN INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 2.000 packages of ENOXAPARIN INJECTION, with a total contract value of $86.48. The award was issued on July 16, 2026, and the item is identified by NSN 6505015058466 and NDC 68249-183-05, ensuring compliance with FDA and DoD pharmaceutical standards. The delivery is FOB destination, meaning the contractor bears all transportation costs and risks until the product reaches the designated delivery point at the Electric Boat Corporation facility in North Stonington, Connecticut. Inspection and acceptance occur at the destination by a government representative, with no variance permitted in the quantity ordered. The product must be shipped via the fastest traceable means, excluding parcel post, and all packaging must be marked with the CAGE code 1UNB0 and SL4701, as well as the NDC identifier, following DoD identification practices. The contractor qualifies as a small business, small disadvantaged business, and women-owned small business, with associated compliance obligations. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the appropriation identifier BX: 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, with Jayne Do serving as the local administrative contact. No formal FAR clauses, MIL-STD references, or detailed inspection criteria are explicitly listed in the documentation, though adherence to USP standards for injectable pharmaceuticals is implied. The delivery order is a one-time, fixed-quantity transaction with no options, modifications, or performance period beyond the single delivery date of July 16, 2026.